Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study

Introduction: This study determined risk factors, obstetric comorbidities, and fetal conditions among HIV-positive mothers to improve their maternal care. Methodology: This retrospective case-control study included HIV-positive pregnant women 18 years of age or older and age-, parity-, and deliv...

Full description

Saved in:
Bibliographic Details
Main Authors: Tung-Che Hung, Li-Cheng Lu, Mei-Hui Lin, Yu-Chia Hu, Chien-Yu Cheng, Shu-Hsing Cheng, Chien-Yu Lee
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2020-08-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/11745
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850148825494192128
author Tung-Che Hung
Li-Cheng Lu
Mei-Hui Lin
Yu-Chia Hu
Chien-Yu Cheng
Shu-Hsing Cheng
Chien-Yu Lee
author_facet Tung-Che Hung
Li-Cheng Lu
Mei-Hui Lin
Yu-Chia Hu
Chien-Yu Cheng
Shu-Hsing Cheng
Chien-Yu Lee
author_sort Tung-Che Hung
collection DOAJ
description Introduction: This study determined risk factors, obstetric comorbidities, and fetal conditions among HIV-positive mothers to improve their maternal care. Methodology: This retrospective case-control study included HIV-positive pregnant women 18 years of age or older and age-, parity-, and delivery method-matched HIV-negative controls between 2011 and 2018. Those who had stillbirth were excluded. Baseline demographics, labor process, CD4 count, plasma HIV viral load, and antiretroviral therapy (ART) regimen were recorded. Fetal conditions were recorded as well. Results: Forty HIV-positive women (45 parities; 22 via NSD, 23 via C/S) were included, with 45 HIV-negative parities as controls. Twenty-nine (72.5%) HIV-positive women had illicit drug use. In the HIV-positive group, 17% received ART prior to first perinatal visit, and 75.6% reached viral suppression pre-delivery. Zidovudine and ritonavir-boosted lopinavir were the majorly prescribed ART. Mild perineal lacerations via NSD were observed in HIV-positive women. Fetal body weight was lower in HIV- and ART-exposed fetuses (2665 vs 3010 g, p < 0.001). Preterm delivery PTB (28.9% vs 8.9%, p= 0.015) and small-for gestational age SGA (28.9% vs 8.8%, p = 0.003) rates were higher in the HIV-positive group. There was no vertical transmission of HIV. Conclusions: HIV-positive women tend to deliver fetuses with low body weight and have higher SGA and PTB rates. Given that most women received zidovudine and protease inhibitors, benefits of newer agents for HIV-positive pregnancies should be studied.
format Article
id doaj-art-c7bb7e23bfc54d19a42d47724645cb91
institution OA Journals
issn 1972-2680
language English
publishDate 2020-08-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-c7bb7e23bfc54d19a42d47724645cb912025-08-20T02:27:07ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802020-08-01140810.3855/jidc.11745Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control studyTung-Che Hung0Li-Cheng Lu1Mei-Hui Lin2Yu-Chia Hu3Chien-Yu Cheng4Shu-Hsing Cheng5Chien-Yu Lee6Department of Infectious Diseases, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, TaiwanDepartment of Gynecology and Obstetrics, Taoyuan General Hospital, Ministry of Health and Welfare, TaoyuanDepartment of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, TaiwanDepartment of Gynecology and Obstetrics, Taoyuan General Hospital, Ministry of Health and Welfare, TaoyuanDepartment of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, TaiwanDepartment of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, TaiwanDepartment of Pediatrics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan Introduction: This study determined risk factors, obstetric comorbidities, and fetal conditions among HIV-positive mothers to improve their maternal care. Methodology: This retrospective case-control study included HIV-positive pregnant women 18 years of age or older and age-, parity-, and delivery method-matched HIV-negative controls between 2011 and 2018. Those who had stillbirth were excluded. Baseline demographics, labor process, CD4 count, plasma HIV viral load, and antiretroviral therapy (ART) regimen were recorded. Fetal conditions were recorded as well. Results: Forty HIV-positive women (45 parities; 22 via NSD, 23 via C/S) were included, with 45 HIV-negative parities as controls. Twenty-nine (72.5%) HIV-positive women had illicit drug use. In the HIV-positive group, 17% received ART prior to first perinatal visit, and 75.6% reached viral suppression pre-delivery. Zidovudine and ritonavir-boosted lopinavir were the majorly prescribed ART. Mild perineal lacerations via NSD were observed in HIV-positive women. Fetal body weight was lower in HIV- and ART-exposed fetuses (2665 vs 3010 g, p < 0.001). Preterm delivery PTB (28.9% vs 8.9%, p= 0.015) and small-for gestational age SGA (28.9% vs 8.8%, p = 0.003) rates were higher in the HIV-positive group. There was no vertical transmission of HIV. Conclusions: HIV-positive women tend to deliver fetuses with low body weight and have higher SGA and PTB rates. Given that most women received zidovudine and protease inhibitors, benefits of newer agents for HIV-positive pregnancies should be studied. https://jidc.org/index.php/journal/article/view/11745pregnancyfetusHIVAIDSantiretroviral therapy
spellingShingle Tung-Che Hung
Li-Cheng Lu
Mei-Hui Lin
Yu-Chia Hu
Chien-Yu Cheng
Shu-Hsing Cheng
Chien-Yu Lee
Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study
Journal of Infection in Developing Countries
pregnancy
fetus
HIV
AIDS
antiretroviral therapy
title Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study
title_full Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study
title_fullStr Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study
title_full_unstemmed Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study
title_short Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study
title_sort characteristics of hiv positive pregnant women and hiv and antiretroviral therapy exposed fetuses a case control study
topic pregnancy
fetus
HIV
AIDS
antiretroviral therapy
url https://jidc.org/index.php/journal/article/view/11745
work_keys_str_mv AT tungchehung characteristicsofhivpositivepregnantwomenandhivandantiretroviraltherapyexposedfetusesacasecontrolstudy
AT lichenglu characteristicsofhivpositivepregnantwomenandhivandantiretroviraltherapyexposedfetusesacasecontrolstudy
AT meihuilin characteristicsofhivpositivepregnantwomenandhivandantiretroviraltherapyexposedfetusesacasecontrolstudy
AT yuchiahu characteristicsofhivpositivepregnantwomenandhivandantiretroviraltherapyexposedfetusesacasecontrolstudy
AT chienyucheng characteristicsofhivpositivepregnantwomenandhivandantiretroviraltherapyexposedfetusesacasecontrolstudy
AT shuhsingcheng characteristicsofhivpositivepregnantwomenandhivandantiretroviraltherapyexposedfetusesacasecontrolstudy
AT chienyulee characteristicsofhivpositivepregnantwomenandhivandantiretroviraltherapyexposedfetusesacasecontrolstudy